Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
CSE:NOVO B
Price:
892.7 DKK
-1.1%
Market Closed
Updated:
May 1, 2024
Novo Nordisk A/S
Net Income (Common)
|
Novo Nordisk A/S
Net Income (Common) Peer Comparison
Comparables:
HLUN A
ALK B
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Novo Nordisk A/S
CSE:NOVO B
|
Net Income (Common)
kr83.7B
|
CAGR 3-Years
26%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
|
H Lundbeck A/S
CSE:HLUN A
|
Net Income (Common)
kr2.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ALK-Abello A/S
CSE:ALK B
|
Net Income (Common)
kr486m
|
CAGR 3-Years
169%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Net Income (Common)?
Net Income (Common)
83.7B
DKK
83.7B
DKK
Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's Net Income (Common) amounts to 83.7B DKK.
What is Novo Nordisk A/S's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
13%
13%
Over the last year, the Net Income (Common) growth was 51%. The average annual Net Income (Common) growth rates for Novo Nordisk A/S have been 26% over the past three years , 17% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
